Psychedelics have been used for millennia in both spiritual and medicinal contexts. Recently, a number of clinical successes with psychedelics have generated considerable excitement; nevertheless, mechanisms underlying their therapeutic efficacy are largely unknown.
Read More Below
Watch Now
Psychedelics have been used for millennia in both spiritual and medicinal contexts. Recently, a number of clinical successes with psychedelics have generated considerable excitement; nevertheless, mechanisms underlying their therapeutic efficacy are largely unknown.
Dr. Dölen will discuss recent evidence from her lab that MDMA targets an evolutionarily ancient mechanism shared with Octopus (Edsinger and Dolen, Current Biology 2018) and may have its therapeutic effects through its ability to reopen the social reward learning critical period (Nardou, et al., Nature, 2019).
Building on this discovery, Dr. Dölen has initiated the PHATHOM project (Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability; www.phathomproject.org), which aims to test the hypothesis that psychedelic drugs as a class act to reopen multiple critical periods across the brain, and that this property can be harnessed for therapeutic benefit.
During this webinar we will discuss:
Speaker Information:
Sponsored by:
Interested in sponsoring this webinar? Contact our friendly sales team here
Analytical Cannabis
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@analyticalcannabis.com
© 2021 Analytical Cannabis. All rights reserved
Analytical Cannabis needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy